09.09.09
William Mann, Ph.D., has been appointed chief executive officer for Helsinn Group’s American subsidiary, Helsinn Therapeutics (U.S.) Inc. Dr. Mann previously served as chief operating officer of the recently acquired Helsinn Therapeutics. He has also held leadership positions with a Swiss multinational in business development and research.
Also, William Brown has been named vice president commercial operations to build a direct sales structure for Helsinn Therapeutics in the U.S. Mr. Brown has experience with multinational groups in the management of supportive care. Previously, he managed the product Aloxi at MGI Pharma.
Dr. Riccardo Braglia, the Helsinn group's chief executive officer said, "Helsinn wishes to implement a new group growth strategy in the United States, placing more and more importance on the project development and acquisition of new business expertise. The appointments of William Mann and William Brown will allow us to consolidate Helsinn's U.S. business, the projects currently in development in cancer supportive care and in gastrointestinal areas and will lay the foundations for further development in North America also from a commercial point of view."
Sign up today for Contracting & Outsourcing 2009!
contractpharma.com/2009conference
Also, William Brown has been named vice president commercial operations to build a direct sales structure for Helsinn Therapeutics in the U.S. Mr. Brown has experience with multinational groups in the management of supportive care. Previously, he managed the product Aloxi at MGI Pharma.
Dr. Riccardo Braglia, the Helsinn group's chief executive officer said, "Helsinn wishes to implement a new group growth strategy in the United States, placing more and more importance on the project development and acquisition of new business expertise. The appointments of William Mann and William Brown will allow us to consolidate Helsinn's U.S. business, the projects currently in development in cancer supportive care and in gastrointestinal areas and will lay the foundations for further development in North America also from a commercial point of view."
Sign up today for Contracting & Outsourcing 2009!
contractpharma.com/2009conference